---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-050203"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T02:49:58.645812+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio Closes $5M Underwritten Public Offering of Units and Warrants

## Summary
- Issued 158,000 Class A Units (common + warrant) and 3,120,688 Class B Units (prefunded warrant + warrant) at $1.525/$1.5249 per unit.
- Gross proceeds $5 million; net proceeds approximately $4.1 million after underwriting discounts and expenses.
- Proceeds to fund Phase 1 trial of PALI-2108, pre-clinical studies, R&D, and working capital.
- Repriced approximately 1,040,217 previously issued warrants to $1.40 per share for participating investor.
- Underwriter Ladenburg Thalmann & Co. Inc.; 45-day overallotment option for up to 491,803 additional shares/warrants.

## SEC filing metadata
- accession: 0001493152-24-050203
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315224050203/0001493152-24-050203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315224050203/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-050203
- JSON: https://secwatch.observer/filing/0001493152-24-050203.json
- Plain text: https://secwatch.observer/filing/0001493152-24-050203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.